Drug distributor Cencora plans to buy Retina Consultants of America from Webster Equity Partners in a $4.6 billion deal. RCA is a management services organization that operates a network of retina ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Shares of Cencora, Inc. (NYSE:COR – Get Free Report) hit a new 52-week high during mid-day trading on Thursday following a stronger than expected earnings report. The stock traded as high as $ ...

Cencora ( (COR)) just unveiled an announcement. Cencora, Inc. has announced its plan to acquire Retina Consultants of America (RCA) for approximately $4.6 billion, aiming to expand its leadership ...

However, prior to this announcement, Cencora's dividend was comfortably covered by both cash flow and earnings. This means that most of its earnings are being retained to grow the business.

If it is predictable over a long period, even low dividend yields can be attractive. However, prior to this announcement, Cencora's dividend was comfortably covered by both cash flow and earnings.

Shares of Cencora Inc. COR inched 0.26% higher to $248.41 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.38% to ...

AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data. Now, Vyalev (foscarbidopa ...